Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 9

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Amortization of intangible assets 
     172,033  
     172,033 
  
    Stock based compensation - restricted stock units and restricted shares 
     912,667  
     1,020,383 
  
    Stock based compensation expense - stock options 
     842,638  
     2,118,649 
  
    Stock based compensation expense - issuance of common stock for services rendered 
     33,450  
     92,202 
  
    Amortization of financing costs 
     11,820  
     867,449 
  
    Accretion of unearned loan discount 
     111,212  
     200,909 
  
    Accretion of loan premium 
     25,758  
     (223,865)
  
    Realized gain on maturity of available-for sale 
     -  
     33,903 
  
    Non-cash lease expense from right-of-use assets 
     49,448  
     (5,215)
  
    Change in fair value of derivative liabilities 
     (3,771) 
     (1,799,339)
  
    Changes in operating assets and liabilities: 

    Prepaid and other current assets 
     (365,135) 
     (87,056)
  
    Accounts payable and accrued expenses 
     (1,111,072) 
     933,495 
  
    Operating lease liabilities 
     (43,807) 
     (33,909)
  
    Other current liabilities 
     -  
     (48,385)
  
    Net cash used in operating activities 
     (13,417,738) 
     (23,938,485)

    CASH FLOWS FROM INVESTING ACTIVITIES: 

    Proceeds from U.S. Treasury Bills (available-for-sale) 
     -  
     14,525,000 
  
    Net cash provided by investing activities 
     -  
     14,525,000 

    CASH FLOWS FROM FINANCING ACTIVITIES: 

    Net proceeds from issuance of common stock 
     15,674,613  
     27,802,939 
  
    Proceeds from exercise of warrants